Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2011-04-14 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
2010年度述职报告（熊焰）
Board/Management Information Classification · 95% confidence The document is a 2010年度述职报告 (2010 Annual Work Report) by an independent director of the company 嘉事堂药业股份有限公司. It details the director's attendance at board meetings, opinions on various company matters including audit firm appointment, use of raised funds, and other governance-related activities during the year 2010. The content focuses on the director's duties, opinions, and oversight activities rather than presenting financial statements or audit results. The document length is 3449 characters, which is relatively short and more consistent with a management or board report rather than a full annual report or audit report. It is not a certification or a brief announcement but a detailed report on the director's work and opinions. This fits best with the category of Board/Management Information (MANG), which includes announcements of changes or reports related to the company's board or senior management activities. Therefore, the classification is MANG with high confidence.
2011-04-14 Chinese
2010年度述职报告（刘建华）
Management Reports Classification · 95% confidence The document is a 2010年度述职报告 (2010 Annual Work Report) by an independent director of 嘉事堂药业股份有限公司. It details the director's attendance at board meetings, opinions on various company matters including audit firm appointment, use of raised funds, and other governance-related activities during the year 2010. The content is a detailed management report on the director's duties and opinions rather than a financial report or announcement. It does not contain financial statements or earnings data, nor is it a notice or announcement of a report publication. It is a management report explaining activities and oversight during the year, fitting the category of Management Reports (MDA). The document length is 3409 characters, which is consistent with a detailed report but not a brief announcement. Therefore, the best classification is Management Reports (MDA).
2011-04-14 Chinese
2010年度述职报告（武文生）
Board/Management Information Classification · 95% confidence The document is a 2010年度述职报告 (2010 Annual Work Report) by an independent director of 嘉事堂药业股份有限公司. It details the director's attendance at board meetings, opinions on various company matters including audit firm appointment, use of raised funds, and other governance-related activities during the year 2010. The document is a narrative report on the director's duties and opinions rather than a financial report or announcement. It does not contain financial statements or earnings data, nor is it a brief announcement or a proxy solicitation. It is a management-related report focusing on the director's work and opinions, which fits best under Board/Management Information (MANG). The document length is 3412 characters, which is relatively short but contains substantive content about management activities and opinions, not just an announcement or certification. Therefore, the best classification is MANG with high confidence.
2011-04-14 Chinese
内幕信息知情人登记和报备制度（2011年4月）
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled '内幕信息知情人登记和报备制度' (Insider Information Insider Registration and Reporting System) for 嘉事堂药业股份有限公司. It outlines the scope of insider information, the responsibilities of insiders, registration and reporting procedures, confidentiality obligations, and penalties for violations. The content focuses on internal governance and compliance related to insider information management rather than financial results, audit opinions, or shareholder meeting materials. There is no indication of financial statements, earnings data, voting results, or capital changes. The document is a governance and compliance policy related to insider information management, which fits best under Governance Information (CGR). The document length (4702 characters) and detailed procedural content support this classification rather than a brief announcement or regulatory filing.
2011-04-14 Chinese
关于公司2010年度募集资金存放与使用情况鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2010年度募集资金存放与使用情况的专项报告" which translates to "2010 Annual Special Report on the Deposit and Use of Raised Funds". It contains detailed audited information about the company's fundraising amount, usage, management, and balance of raised funds for the year 2010. The report includes auditor's verification and compliance with Shenzhen Stock Exchange regulations on raised funds management. It is a specialized report focusing on the use and management of capital raised through stock issuance, not a general annual report or earnings release. This type of document is a standalone audit or verification report related to capital usage, fitting the category of Audit Report / Information (AR). The document length is over 8,000 characters and contains substantive financial data and auditor opinions, so it is not a mere announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2010
2011-04-14 Chinese
关于2010年度内部控制的自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2010年度内部控制的自我评价报告" which translates to "2010 Annual Internal Control Self-Evaluation Report." It details the company's internal control system, governance structure, risk assessment, internal audit, and management controls. The content is focused on internal control evaluation rather than full financial statements or audit opinions. It is not an annual report (10-K) or audit report (AR) but rather a self-assessment of internal controls. This type of document aligns with the category of Audit Report / Information (AR), which includes internal control reports and related evaluations. The document length (8167 characters) and detailed content support it being a full report rather than a brief announcement or certification. Therefore, the best classification is AR with high confidence. FY 2010
2011-04-14 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.